PU.1 redistribution as a new targeted therapy for AML by Samuel John Taylor - great work presented at the Molecular Hematopoiesis workshop today!

Interested in the non-canonical function of EZH2 in leukemia and lymphoma, and how to target it? Come and see us tonight at poster 360! (we are also right next to the bar 🥂🍷) #EHA2024

Our lab’s prize winner 😍 congrats Grace Meaker !

Just got a coffee at #EHA2024 (thanks Sanofi ) and I was told I was the first person to ask for a coffee in a reusable cup. So come on everyone, bring your own cups next year to reduce waste and create a more sustainable congress ! YoungEHA European Hematology Association

👇👇👇

Amazing talk of Guillaume P. Andrieu on Notch1-driven mitochondrial stress in T-ALL, with Alexandra B. Veloso chairing this session like a pro! #EHA2024

When in Madrid… #EHA2024

Last day of #EHA2024, time flies when you are having fun! ⏱️ This morning’s session starts with a very elegant story presented by Ruud Delwel on targeting EVI1 complexes. Congrats Dorien Pastoors with the impressive work! 👏

👇 Second author and last author presenting a poster together, spreading the latest news on dual EZH2 and HDAC targeting ! Well done, Thomas Slegers 👏Our science is in good hands with you! (first author Alexandra B. Veloso was too busy showing her work on TLX1/3 😂) #EHA2024

Already looking forward to #EHA2025 after this year’s #EHA2024 - as the newest member of the YoungEHA committee, I’ll be putting my shoulders under next year’s #YERM youngEHA research meeting! Stay tuned for updates, for everyone young at heart with a passion for hematology🩸

Short stop in Leuven before returning to Oxford after #EHA2024 for the PhD defense of my colleague Charlien Vandersmissen ! Great work on selective PSEN1 targeting in T-ALL 💊 Whoever gets to have her in their team in the future is very very lucky!

📢Today we launched our 6th internal call for projects within the #VIBGrandchallenges Program! New and validation projects can be submitted, focusing on increasing VIB's societal impact. After a review procedure with external experts, the projects will be selected in June 2025👏

🚀 New research from #EHA2024! Thomas Slegers and Dr Marlies Vanden Bempt from KU Leuven presented on dual targeting of EZH2 and HDAC in haematological cancers, showing strong synergistic effects.

I love science but I also love visiting home and being instantly recognised as the amazing human that I am by my most furry friends 😍

I’m currently writing/attempting to write an ERC StG, and it feels like I’m trying to compete in the #Olympics of academia. Do I get a medal when I submit, please? 🙃 also: there should be a prize for the funniest acronym!

>1300 T-ALL samples sequenced and analyzed, this is an amazing study and an important resource for our field! Congrats to all the authors! 👏

After-summer-break reminder 🏖️📢 Send your abstract to the 3rd European Hematology Association Research conference Join us in Malaga 17-20th March☀️to discuss latest research on transcriptional control and chromatin alterations in hematopoiesis info 👇 ehaweb.org/meetings/eha-r… YoungEHA

I see all the messages about #ISEH2024 and now I regret that I’m not going this year. Have fun everyone, I remember it from last year as one of the very best meetings for networking! Look at us, all hematology researchers that had never met before 👇😍